Non Small Cell Lung Cancer

You are here

Non Small Cell Lung Cancer

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Lung Cancer Video Library Mandarin - Evolving Standards for Molecular Testing in Advanced NSCLC
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer
Lung Cancer Video Library Mandarin - Consolidation Radiation After a Good Response to 1st Line
For our Mandarin-speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer
Lung Cancer Video Library Mandarin - Immunotherapy Combinations in Advanced Squamous Non Small Cell Lung Cancer
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer
Lung Cancer Video Library Mandarin - Does Immunotherapy Work with Driver Mutations like EGFR, ALK
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer
Lung Cancer Video Library Mandarin - Chemotherapy Immunotherapy Combinations in Advanced Non-Squamous NSCLC
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer

Articles

JOIN GRACE - Live in Seattle, November 10, 2018 ~Local Therapies for Metastatic Lung Cancer
​​​​​​ The Global Resource for Advancing Cancer Education (GRACE) in partnership with Swedish Cancer Institute presents: Local Therapies for...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer
My Top 10 ASCO 2017 Lung Cancer Presentations
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer, Small Cell Lung Cancer
Can “Local” Therapy in Metastatic Lung Cancer Alter the Path for Systemic Disease?
After completing my unpacking from ASCO and beginning to see a path of light as I dig out from under the backup of work that accumulated, I wanted to...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Surgical, Radiation Therapy, Non Small Cell Lung Cancer
Clinical Trial Spotlight: Should a Third Generation EGFR Inhibitor be First Line Therapy for EGFR Mutation-Positive NSCLC?
Dr. Jack West introduces the question of whether third generation EGFR tyrosine kinase inhibitors osimertinib and rociletinib should be used as first line therapy rather than for acquired resistance, including discussing key clinical trials on the topic.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Clinical Trials, Molecular Testing, Non Small Cell Lung Cancer

Community Forum

Videos now posted! OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a live and webcast discussion on Local Therapies for...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Chemotherapy, 3rd Line and beyond, Scans - PET-CT, etc., Surgical, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer
Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?
Hi Grace Members, Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who,...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Drugs, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Procedures & Treatments, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Investigational Agents, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer
Progression on Tarceva - T790m negative
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Targeted Therapies - EGFR, Targeted Therapy, Molecular Testing, Immunotherapies, Non Small Cell Lung Cancer
Keytruda for Adenocarcinoma (NSCLC), first PET-CT result
Hello friends, My mom, (aged 77, Adenocarcinoma NSCLC, Stage 4, EGFR and ALK negative) was diagnosed in 2014, underwent VATS and pleurodesis,...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Immunotherapies, Non Small Cell Lung Cancer
Stage IIIb ALK NSCLC first line treatment
This question is not for a specific patient, it is designed to understand how oncologists would approach this problem. There’s a 50 year old stage...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies – ALK, Non Small Cell Lung Cancer